Table 2.
Placebo penile block (n = 60) | Bupivacaine penile block (n = 56) | p-value | |
---|---|---|---|
Inpatient medications | |||
Periurethral Lidocaine Jelly Usage (%) | 8% | 16% | 0.20 |
Anticholinergic, Usage (%) | 28% | 25% | 0.73 |
Anticholinergic (# doses of oxybutynin 5 mg) | 0.8 ± 2.1 | 0.5 ± 0.9 | 0.21 |
Opiates (mean ± SD, mg of MED) | 41.2 ± 45.5 | 31.5 ± 24.6 | 0.16 |
IV Ketorolac Usage | 73% | 84% | 0.17 |
IV Ketorolac (mean ± SD, mg) | 49.5 ± 34.8 | 57.3 ± 32.5 | 0.62 |
Post-discharge medications | |||
Opiates (mean ± SD, mg of MED) | 68.5 ± 64.3 | 47.3 ± 51.1 | 0.05 |